B-Cell-Deficient and CD8 T-Cell-Depleted Gnotobiotic Pigs for the Study of Human Rotavirus Vaccine-Induced Protective Immune Responses
Abstract
Genetically modified pigs have become available recently. In this study, we established the gnotobiotic pig model of human rotavirus (HRV) infection using cloned pigs with homozygous disruption in the gene encoding immunoglobulin heavy chain (HCKO), which totally impairs B-cell development. To clarify importance of B cells and cytotoxic T cells in rotavirus immunity, CD8 cells in a subset of the pigs were depleted by injecting antipig CD8 antibodies and the immune phenotypes of all pigs were examined. HCKO pigs, CD8 cell-depleted HCKO pigs, and wild-type (WT) pigs were vaccinated with an attenuated HRV vaccine and challenged with virulent HRV. Protection against HRV infection and diarrhea was assessed postchallenge and detailed T-cell subset responses were determined pre- and postchallenge. Significantly longer duration of virus shedding was seen in vaccinated HCKO pigs than in WT pigs, indicating the importance of B cells in vaccine-induced protective immunity. Vaccinated HCKO/CD8− pigs shed significantly higher number of infectious virus than WT pigs and non-CD8-depleted HCKO pigs, indicating the importance of CD8 T cells in controlling virus replication. Therefore, both B cells and CD8 T cells play an important role in the protection against rotavirus infection. HCKO and HCKO/CD8− pigs did not differ significantly in diarrhea and virus shedding postchallenge; increased CD4 and CD8− γδ T-cell responses probably compensated partially for the lack of CD8 T cells. This study demonstrated that HCKO pigs can serve as a valuable model for dissection of protective immune responses against viral infections and diseases.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Akkina R. New generation humanized mice for virus research: comparative aspects and future prospects. Virology 2013;435:14–28.
2.
Azevedo MS, Yuan L, Jeong KI, et al. Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus. J Virol 2005;79:5428–5436.
3.
Blutt SE, Miller AD, Salmon SL, Metzger DW, and Conner ME. IgA is important for clearance and critical for protection from rotavirus infection. Mucosal Immunol 2012;5:712–719.
4.
Blutt SE, Warfield KL, Estes MK, and Conner ME. Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity. J Virol 2008;82:3135–3138.
5.
Butler JE, Lager KM, Splichal I, et al. The piglet as a model for B cell and immune system development. Vet Immunol Immunopathol 2009;128:147–170.
6.
Casadevall A, and Pirofski LA. Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting ‘unnatural’ immunity. J Exp Med 2003;197:1401–1404.
7.
Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002;20:251–255.
8.
Dharakul T, Labbe M, Cohen J, et al. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. J Virol 1991;65:5928–5932.
9.
Dunn CS, Mehtali M, Houdebine LM, Gut JP, Kirn A, and Aubertin AM. Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits. J Gen Virol 1995;76(Pt 6):1327–1336.
10.
Franco MA, and Greenberg HB. Immunity to rotavirus in T cell deficient mice. Virology 1997;238:169–179.
11.
Franco MA, and Greenberg HB. Immunity to rotavirus infection in mice. J Infect Dis 1999;179 Suppl 3:S466–S469.
12.
Franco MA, and Greenberg HB. Immunity to homologous rotavirus infection in adult mice. Trends Microbiol 2000;8:50–52.
13.
Gerner W, Kaser T, and Saalmuller A. Porcine T lymphocytes and NK cells—an update. Dev Comp Immunol 2009;33:310–320.
14.
Goenka R, Parent MA, Elzer PH, and Baldwin CL. B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus. J Infect Dis 2011;203:1136–1146.
15.
Kim YB. Gnotobiotic miniature swine for immunobiology and medicine. Microb Ecol Helath Dis 2007;19:251–252.
16.
Lee K, Kwon DN, Ezashi T, et al. Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci U S A 2014;111:7260–7265.
17.
Li L, Li Q, Bao Y, et al. RNAi-based inhibition of porcine reproductive and respiratory syndrome virus replication in transgenic pigs. J Biotechnol 2014;171:17–24.
18.
Liu F, Wen K, Li G, et al. Dual functions of Lactobacillus acidophilus NCFM as protection against rotavirus diarrhea. J Pediatr Gastroenterol Nutr 2014;58:169–176.
19.
Luo Y, Lin L, Bolund L, Jensen TG, and Sørensen CB. Genetically modified pigs for biomedical research. J Inherit Metab Dis 2012;35:695–713.
20.
McNeal MM, VanCott JL, Choi AH, et al. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J Virol 2002;76:560–568.
21.
Meurens F, Summerfield A, Nauwynck H, Saif L, and Gerdts V. The pig: a model for human infectious diseases. Trends Microbiol 2012;20:50–57.
22.
Meyer RC, Bohl EH, and Kohler EM. Procurement and maintenance of germ-free seine for microbiological investigations. Appl Microbiol 1964;12:295–300.
23.
Offit PA, and Dudzik KI. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J Virol 1990;64:6325–6328.
24.
Ramsoondar J, Vaught T, Ball S, et al. Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation 2009;16:164–180.
25.
Reid W, Sadowska M, Denaro F, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 2001;98:9271–9276.
26.
Ren RB, Costantini F, Gorgacz EJ, Lee JJ, and Racaniello VR. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 1990;63:353–362.
27.
Saif L, Yuan L, Ward L, and To T. Comparative studies of the pathogenesis, antibody immune responses, and homologous protection to porcine and human rotaviruses in gnotobiotic piglets. 1st International Rushmore Conference on Mechanisms in the Pathogenesis of Enteric Diseases. Rapid City, SD: Plenum Press Div Plenum Publishing Corp., 1995.
28.
Sato M, Miyoshi K, Nagao Y, et al. The combinational use of CRISPR/Cas9-based gene editing and targeted toxin technology enables efficient biallelic knockout of the alpha-1,3-galactosyltransferase gene in porcine embryonic fibroblasts. Xenotransplantation 2014;21:291–300.
29.
Scott BB, Velho TA, Sim S, and Lois C. Applications of avian transgenesis. ILAR J 2010;51:353–361.
30.
Sellin CI, and Horvat B. Current animal models: transgenic animal models for the study of measles pathogenesis. Curr Top Microbiol Immunol 2009;330:111–127.
31.
Sinkora M, and Butler JE. The ontogeny of the porcine immune system. Dev Comp Immunol 2009;33:273–283.
32.
Stepanova H, Pavlova B, Stromerova N, et al. Cell-mediated immune response in swine infected with Mycobacterium avium subsp. avium. Vet Immunol Immunopathol 2011;142:107–112.
33.
Suzuki T, Sundt TM 3rd, Mixon A, and Sachs DH. In vivo treatment with antiporcine T cell antibodies. Transplantation 1990;50:76–81.
34.
Swindle MM, Makin A, Herron AJ, Clubb FJ Jr., and Frazier KS. Swine as models in biomedical research and toxicology testing. Vet Pathol 2012;49:344–356.
35.
Taube S, Kolawole AO, Hohne M, et al. A mouse model for human norovirus. mBio 2013;4:e00450-13.
36.
Tesson L, Cozzi J, Ménoret S, et al. Transgenic modifications of the rat genome. Transgenic Res 2005;14:531–546.
37.
VanCott JL, McNeal MM, Flint J, Bailey SA, Choi AH, and Ward RL. Role for T cell-independent B cell activity in the resolution of primary rotavirus infection in mice. Eur J Immunol 2001;31:3380–3387.
38.
Verma N, Rettenmeier AW, and Schmitz-Spanke S. Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies. Proteomics 2011;11:776–793.
39.
Vodicka P, Smetana K Jr., et al. The miniature pig as an animal model in biomedical research. Ann N Y Acad Sci 2005;1049:161–171.
40.
Walters EM, and Prather RS. Advancing swine models for human health and diseases. Mo Med 2013;110:212–215.
41.
Ward LA, Rosen BI, Yuan L, and Saif LJ. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol 1996;77(Pt 7):1431–1441.
42.
Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 2003;16:17–24.
43.
Ward RL, McNeal MM, and Sheridan JF. Development of an adult mouse model for studies on protection against rotavirus. J Virol 1990;64:5070–5075.
44.
Wei C, Liu J, Yu Z, Zhang B, Gao G, and Jiao R. TALEN or Cas9- rapid, efficient and specific choices for genome modifications. J Genet Genomics 2013;40:281–289.
45.
Wen K, Bui T, Li G, et al. Characterization of immune modulating functions of gamma delta T cell subsets in a gnotobiotic pig model of human rotavirus infection. Comp Immunol Microbiol Infect Dis 2012;35:289–301.
46.
Wen K, Li G, Bui T, et al. High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 2012;30:1198–1207.
47.
Wen K, Li G, Yang X, et al. CD4+ CD25- FoxP3+ regulatory cells are the predominant responding regulatory T cells after human rotavirus infection or vaccination in gnotobiotic pigs. Immunology 2012;137:160–171.
48.
Wiesel M, and Oxenius A. From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help. Eur J Immunol 2012;42:1080–1088.
49.
Yamane H, and Paul WE. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev 2013;252:12–23.
50.
Yuan L, and Saif LJ. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Vet Immunol Immunopathol 2002;87:147–160.
51.
Yuan L, Ward LA, Rosen BI, To TL, and Saif LJ. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol 1996;70:3075–3083.
52.
Yuan L, Wen K, Azevedo MS, Gonzalez AM, Zhang W, and Saif LJ. Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs. Vaccine 2008;26:3322–3331.
Information & Authors
Information
Published In
Copyright
Copyright 2016, Mary Ann Liebert, Inc.
History
Published online: 7 March 2016
Published in print: March 2016
Published ahead of print: 29 January 2016
Topics
Authors
Author Disclosure Statement
The authors declare no conflict of interest.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.